Boston Scientific Corp. (NYSE:BSX)

CAPS Rating: 3 out of 5

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

Recs

1
Player Avatar TMFBreakerJava (99.47) Submitted: 7/12/2009 2:41:41 AM : Outperform Start Price: $9.99 BSX Score: -104.58

They are generating lots of cash and rapidly paying down debt. Insider selling last fall was induced by the financial crisis and does not reflect a lack of faith in the business. Gross margin of 70%. They will likely benefit from universal health care as they will make up on volume any reduction in prices imposed by the new regime.

Featured Broker Partners


Advertisement